SICKLE CELL ANEMIA: THE IMPORTANCE OF EARLY TREATMENT
Abstract
Sickle cell anemia is a hereditary hemoglobinopathy with high global prevalence, characterized by a genetic mutation that produces hemoglobin S, responsible for the deformation of red blood cells, chronic hemolysis, and vaso-occlusive events. This study aimed to analyze the importance of early diagnosis, with emphasis on neonatal screening, and to highlight the role of the biomedical professional in this process. This is a qualitative, descriptive, and bibliographic research, based on scientific articles, guidelines, and official documents published between 2014 and 2025. The findings show that early identification of the disease enables the adoption of prophylactic and therapeutic measures that significantly reduce morbidity and mortality, in addition to improving patients' quality of life. In this context, the biomedical professional plays an essential role in performing and interpreting laboratory tests, such as complete blood count, hemoglobin electrophoresis, and high-performance liquid chromatography (HPLC), which are fundamental for the diagnosis and monitoring of the disease. It is concluded that early diagnosis, combined with the qualified performance of the biomedical professional and the expansion of neonatal screening programs, is crucial for the effective control of sickle cell anemia and for promoting better clinical outcomes.
Author Biographies
Final-year Biomedical Sciences student at the Centro Universitário Fametro, with an interest in clinical analysis and aesthetics.
Undergraduate student in Biomedical Sciences at the Centro Universitário Fametro, with an interest in clinical analysis and aesthetics.
Sarah Silva is an undergraduate student in Biomedicine at Faculdade Metropolitana de Manaus (FAMETRO), currently in her eighth semester. She has an interest in the fields of clinical analysis, hematology, and scientific research, with a focus on studies aimed at the diagnosis and understanding of diseases. She actively participates in academic production, with dedication to the development of scientific work and the expansion of knowledge in the health field.
References
AHMED, R. et al. CRISPR/Cas9 system as a promising therapy in thalassemia and sickle cell disease: a systematic review of clinical trials. Molecular Biotechnology, 2026.
AKINSHEYE, I.; KLINGS, E. S. Sickle cell anemia and vascular dysfunction: the nitric oxide pathway. Blood, 2010.
ALF, M. et al. Terapia gênica para a doença falciforme: às portas de um tratamento promissor? Hematology, Transfusion and Cell Therapy, 2024.
BRASIL. Ministério da Saúde. Manual de diagnóstico e tratamento de doenças falciformes. Brasília: Ministério da Saúde, 2001.
BRASIL. Ministério da Saúde. Triagem neonatal biológica: manual técnico. Brasília: Ministério da Saúde, 2016.
BRASIL. Ministério da Saúde. Doença falciforme: diretrizes básicas da linha de cuidado. Brasília: Ministério da Saúde, 2018.
BROUSSE, V.; BUFFET, P.; REES, D. The spleen and sickle cell disease: the sick(led) spleen. British Journal of Haematology, v. 166, n. 2, p. 165–176, 2014.
COSTA, P. N. Anemia falciforme, diagnóstico precoce e aconselhamento genético na doença falciforme: uma revisão de literatura. Revista JRG de Estudos Acadêmicos, v. 7, n. 15, p. 1–27, jul./dez. 2024.
FIGUEIREDO, A. K. B. et al. Anemia falciforme: abordagem diagnóstica laboratorial. Revista de Ciências da Saúde Nova Esperança, João Pessoa, v. 12, n. 1, p. 98–105, 2014.
GASTON, M. H. et al. Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial. New England Journal of Medicine, v. 314, n. 25, p. 1593–1599, 1986.
HEBBEL, R. P. et al. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood, 2004.
HOLDFORD, D. A. Economic burden of sickle cell disease in the United States. Pharmacoeconomics, 2021.
JESUS, J. A.; CREMONESE, L. Doença falciforme: revisão de literatura sobre diagnóstico e tratamento. Revista Brasileira de Análises Clínicas, v. 51, n. 2, p. 139–146, 2019.
KANSAL, R. Curing sickle cell disease by allogeneic hematopoietic stem cell transplantation toward in vivo HSC gene therapy. Genes, 2025.
KATO, G. J. et al. Sickle cell disease. Nature Reviews Disease Primers, v. 4, 2018.
KIM-SHAPIRO, D. B.; GLADWIN, M. T. Hemoglobin and nitric oxide: mechanisms in sickle cell disease. Journal of Clinical Investigation, 2018.
LIMA, E. G. et al. Aspectos laboratoriais e sociais de paciente portador de anemia falciforme. Revista Recifaqui, v. 2, n. 12, p. 146–162, 2022.
MANWANI, D.; FRENETTE, P. S. Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies. Blood, v. 122, 2013.
MARQUES, V. et al. Revendo a anemia falciforme: sintomas, tratamentos e perspectivas. Revista Científica da Faculdade de Educação e Meio Ambiente (FAEMA), v. 3, n. 1, p. 39–61, jan./jun. 2012.
PEREIRA, L. M.; VALLEJO, N. M. A importância do diagnóstico da doença falciforme. Revista FT, 2023.
PORTO, A. S. et al. Diagnóstico e tratamento da anemia falciforme: revisão de literatura. Revista Multidisciplinar do Nordeste Mineiro, v. 1, 2020.
REES, D. C.; WILLIAMS, T. N.; GLADWIN, M. T. Sickle-cell disease. The Lancet, v. 376, p. 2018–2031, 2010.
REITER, C. D. et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, v. 8, p. 1383–1389, 2002.
SILVA, N. C. H. et al. Principais técnicas para o diagnóstico da anemia falciforme: uma revisão de literatura. Cadernos de Graduação – Ciências Biológicas e da Saúde, v. 3, n. 2, p. 33–46, nov. 2017.
SOCIEDADE BRASILEIRA DE HEMATOLOGIA E HEMOTERAPIA. Consenso brasileiro sobre doença falciforme. São Paulo: SBHH, 2020.
THOMAS, A. N.; PATEL, R. K.; SERJEANT, G. R. Newborn screening for sickle cell disease: principles and practice. Journal of Clinical Pathology, v. 72, n. 9, p. 587–593, 2019.
VICHINSKY, E. P. et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. New England Journal of Medicine, v. 342, n. 25, p. 1855–1865, 2000.
WARE, R. E.; AYLING, P. Sickle cell disease. The Lancet, v. 390, p. 311–323, 2017.
WHITE, S. L.; HART, K.; KOHN, D. B. Diverse approaches to gene therapy of sickle cell disease. Annual Review of Medicine, 2023.
ZAGO, M. A.; PINTO, A. C. Fisiopatologia das doenças falciformes: da mutação genética à insuficiência de múltiplos órgãos. Revista Brasileira de Hematologia e Hemoterapia, v. 29, p. 207–214, 2007.
ZAGO, M. A.; PINTO, A. C. Fisiopatologia e diagnóstico laboratorial da doença falciforme. Revista Brasileira de Hematologia e Hemoterapia, v. 39, n. 1, p. 54–62, 2017.
License
Copyright (c) 2026 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.